Pharmala Biotech Holdings (MDMA) Total Liabilities

MDMA Total Liabilities in 2022: $713.76K

According to Pharmala Biotech Holdings latest financial reports the total liabilities of MDMA is $713.76K, an increase of 142.82% to 2022. At the end of 2022 company had $293.95K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Pharmala Biotech Holdings is responsible for during its operational activities.

Pharmala Biotech Holdings (MDMA) Total Liabilities History from 2023 to 2022

MDMA Total Liabilities by year

View the Top Total Liabilies Stocks